Physician profile
James Hunt
NPI 1013136340
$574.26
in general payments reported to CMS, 2019-2025
18 companies · $46.08 in 2025
The $46.08 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $54.53 · 2021: $111 · 2022: $103 · 2024: $72.82 · 2025: $46.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $118.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $120.71 | 2019-2021 | |
| Horizon Therapeutics Plc | $72.08 | 2021-2022 | |
| Boston Scientific Corporation | $50.69 | 2024 | |
| Stryker Corporation | $46.08 | 2025 | Spinejack |
| Collegium Pharmaceutical, INC. | $39.46 | 2019-2020 | |
| Abbvie INC. | $31.87 | 2022 | |
| Bioventus LLC | $23.02 | 2021 | |
| Pacira Therapeutics, INC. | $22.13 | 2019 | |
| Lundbeck LLC | $22.13 | 2024 | Vyepti |
| Stimwave Technologies Incorporated | $21.54 | 2019 | |
| Scilex Pharmaceuticals INC. | $20.86 | 2021 | |
| Nalu Medical, INC. | $17.33 | 2022 | |
| Nevro Corp. | $17.22 | 2020 | |
| Tersera Therapeutics LLC | $17.17 | 2019 | |
| Baudax Bio INC. | $15.75 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.40 | 2019 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 | |
| Kci USA, INC. | $11.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.